LeonaBio (LONA) PT Lowered to $15 at Mizuho Aug 19, 2026 06:40AM
LeonaBio, Inc. (LONA) Tops Q2 EPS by 32c Aug 17, 2026 06:13AM
LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development Aug 17, 2026 04:41AM
LeonaBio to present lasofoxifene data at breast cancer summit Aug 12, 2026 07:01AM
Citizens Upgrades LeonaBio (LONA) to Market Outperform Jul 30, 2026 03:03AM


Jul 30, 2026 03:03AM Citizens Upgrades LeonaBio (LONA) to Market Outperform
Jun 4, 2026 07:01AM LeonaBio presents ALS drug at development summit, plans phase 2 trial
May 27, 2026 03:46AM Piper Sandler Starts LeonaBio (LONA) at Overweight
May 7, 2026 09:20AM LeonaBio adds three directors to board, John Fluke retires
Apr 7, 2026 07:15AM LeonaBio (LONA) Reiterated at Overweight by Cantor Fitzgerald Amid Growing Investor Interest
Apr 6, 2026 06:43AM LeonaBio (LONA) PT Raised to $16 at Mizuho
Feb 26, 2026 06:32AM Cantor Fitzgerald Starts LeonaBio (LONA) at Overweight
Feb 18, 2026 04:36PM Mizuho Upgrades LeonaBio (LONA) to Outperform
Feb 3, 2026 07:00AM LeonaBio names Mark Kubik as chief business officer
Jan 20, 2026 04:44PM LeonaBio (LONA) files for 5.5M share offering by selling stockholders
Jan 20, 2026 04:26PM LeonaBio (LONA) files for 58.46M share offering by selling stockholders